North America Human Leukocyte Antigen (HLA) Testing Market Forecast to 2028

Report Code : BMIRE00025763 | Region : North America | Industry : Biotechnology | Published Date : 07/Sep/2022
North America Human Leukocyte Antigen (HLA) Testing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product and service (Reagents & Consumables, Instruments, and Software & Services), Technology (Molecular Assay Technologies and Non-Molecular Assay Technologies), and End User (Independent Reference Laboratories, Hospital and Transplant Centers, and Others)

The North America human leukocyte antigen (HLA) testing market is expected to grow from US$ 324.49 million in 2022 to US$ 504.72 million by 2028; it is estimated to grow at a CAGR of 7.6% from 2022 to 2028.

Human leukocyte antigens (HLAs) are specialized proteins present on all cell surfaces of the human body except red blood cells. HLA testing has significant application in organ transplantation, which can be recommended as a part of the treatment of kidney failure, chronic liver cirrhosis, and chronic heart disease, among other medical issues. The growing prevalence of chronic diseases and organ failure leads to high demand for organ transplant procedures, as well as HLA testing. Before transplantation, HLA testing is performed to check tissue compatibility between patients and donors to avoid graft rejection. In recent years, transplantation has become a successful practice area. Governments of various countries are taking initiatives to spread awareness about the need for organ donation and the benefits of organ transplantation in certain treatment procedures. For instance, the Organ Procurement and Transplantation Network (OPTN) has implemented a few strategies to improve the number of organ transplantation procedures in the US. These strategies focus on increasing the number of organ and tissue transplants among patients with end-stage organ disease, altering the current organ distribution, and modifying the organ transplantation waitlist by redistributing the existing organ soppy. Furthermore, the OPTN has used out-of-box strategies to improve organ transplantation. These innovative strategies include the optimized use of organs obtained from deceased patients [e.g., donation after cardiac death (DCD) or brain-dead donors], reducing discards of organs, promoting living donation, and improving the rate of potential organ donation authorization. Thus, the growing demand for organ transplantation leads to the requirement of a more substantial number of HLA testing kits and consumables, which drives the HLA testing market.

With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the north america human leukocyte antigen (HLA) testing market at a notable CAGR during the forecast period.

North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

North America Human Leukocyte Antigen (HLA) Testing Market Segmentation

The North America human leukocyte antigen (HLA) testing market is segmented into product & services, technology, end user, and country. Based on product & services, the market is segmented into reagents & consumables, instruments, and software & services. In terms of technology, the North America human leukocyte antigen (HLA) testing market is divided into molecular assay technologies and non-molecular assay technologies. The molecular assay technologies segment is sub segmented into PCR-based molecular assays, sequencing-based molecular assays, and others. Based on end user, the market is divided into independent reference laboratories, hospital and transplant centers, and others. Based on country, the North America human leukocyte antigen (HLA) testing market is segmented into the US, Mexico, and Canada.

North America Human Leukocyte Antigen (HLA) Testing Market — Companies Mentioned

THERMO FISHER SCIENTIFIC INC.; CareDx; QIAGEN; Illumina, Inc.; Bio-Rad Laboratories, Inc.; TBG Diagnostics Limited; F. HOFFMANN-LA ROCHE LTD.; Takara Bio Inc.; Luminex Corporation; Omixon Inc.; The Sequencing Center; HistoGenetics LLC; CD Genomics; Quintara Biosciences; and CREATIVE BIOLABS, INC. are among the major companies operating in the North America human leukocyte antigen (HLA) testing market.

The List of Companies - North America Human Leukocyte Antigen (HLA) Testing Market

● THERMO FISHER SCIENTIFIC INC.                            

● CareDx                                                                     

● QIAGEN                                                                                              

● Illumina, Inc.                                                                     

● Bio-Rad Laboratories, Inc.                                           

● TBG Diagnostics Limited                                                               

● F. HOFFMANN-LA ROCHE LTD.                                  

● Takara Bio Inc.                                                                  

● Luminex Corporation                                                    

● Omixon Inc.                                                                       

● The Sequencing Center                

● HistoGenetics LLC

● CD Genomics

● Quintara Biosciences

● CREATIVE BIOLABS, INC.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Human Leukocyte Antigen (HLA) Testing Market – By Product and Services

1.3.2 North America Human Leukocyte Antigen (HLA) Testing Market – By Technology

1.3.3 North America Human Leukocyte Antigen (HLA) Testing Market – By End User

1.3.4 North America Human Leukocyte Antigen (HLA) Testing Market – By Country

2. North America Human Leukocyte Antigen (HLA) Testing Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Human Leukocyte Antigen (HLA) Testing Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America – PEST Analysis

4.3 Expert Opinion

5. North America Human Leukocyte Antigen (HLA) Testing Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Number of Plasma Donation and Organ Transplantation Procedures

5.1.2 Expanding Range of Applications of HLA Testing

5.2 Market Restraints

5.2.1 Errors in Accuracy

5.3 Market Opportunities

5.3.1 Rising Government Funding for Organ Donation

5.4 Future Trends

5.4.1 Technological Advancements in Field of Histocompatibility

5.5 Impact Analysis

6. North America Human Leukocyte Antigen (HLA) Testing Market – Analysis

6.1 North America Human Leukocyte Antigen (HLA) Testing Market Revenue Forecast and Analysis

7. North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 – by Product and Services

7.1 Overview

7.2 North America Human Leukocyte Antigen (HLA) Testing Market Share, By Product and Services 2022 & 2028 (%)

7.2.1 North America: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

7.3 Reagents and Consumables

7.3.1 Overview

7.3.2 Reagents and Consumables: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)

7.4 Instruments

7.4.1 Overview

7.4.2 Instruments: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)

7.5 Software and Services

7.5.1 Overview

7.5.2 Software and Services : North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)

8. North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028– by Technology

8.1 Overview

8.2 North America Human Leukocyte Antigen (HLA) Testing Market, By Technology 2022 & 2028 (%)

8.2.1 North America: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

8.2.1.1 North America: North America Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

8.3 Molecular Assay Technologies

8.3.1 Overview

8.3.2 Molecular Assay Technologies: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

8.3.3 PCR-Based Molecular Assays

8.3.3.1 Overview

8.3.3.2 PCR-Based Molecular Assays: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

8.3.4 Sequencing-Based Molecular Assays

8.3.4.1 Overview

8.3.4.2 Sequencing-Based Molecular Assays: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

8.3.5 Others

8.3.5.1 Overview

8.3.5.2 Others: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

8.4 Non-Molecular Assay Technologies

8.4.1 Overview

8.4.2 Non-Molecular Assay Technologies: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

9. North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028– by End User

9.1 Overview

9.2 North America Human Leukocyte Antigen (HLA) Testing Market, By End User 2022 & 2028 (%)

9.2.1 North America: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

9.3 Independent Reference Laboratories

9.3.1 Overview

9.3.2 Independent Reference Laboratories: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

9.4 Hospital & Transplant Centers

9.4.1 Overview

9.4.2 Hospital & Transplant Centers: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

9.5 Others

9.5.1 Overview

9.5.2 Others: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

10. North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028– by Country

10.1 North America: North America Human Leukocyte Antigen (HLA) Testing Market

10.1.1 Overview

10.1.2 North America: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

10.1.3 North America: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.1.4 North America: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.4.1 North America: North America Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.5 North America: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.1.6 North America: North America Human Leukocyte Antigen (HLA) Testing Market, by Country, 2022 & 2028 (%)

10.1.6.1 US: North America Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.1 US: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.2 US: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.1.6.1.3 US: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.1.3.1 US: North America Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.1.4 US: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.1.6.2 Canada: North America Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.1 Canada: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.2 Canada: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.1.6.2.3 Canada: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.2.3.1 Canada: North America Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.2.4 Canada: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.1.6.3 Mexico: North America Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.1 Mexico North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.2 Mexico: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.1.6.3.3 Mexico: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.3.3.1 Mexico: North America Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.3.4 Mexico: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

11. North America Human Leukocyte Antigen (HLA) Testing Market – Industry Landscape

11.1 Overview

11.2 Growth Strategies in the North America Human Leukocyte Antigen (HLA) Testing Market (%)

11.3 Organic Developments

11.3.1 Overview

11.4 Inorganic Developments

11.4.1 Overview

12. Company Profiles

12.1 THERMO FISHER SCIENTIFIC INC.

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 CareDx

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 QIAGEN

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Illumina, Inc.

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Bio-Rad Laboratories, Inc.

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 TBG Diagnostics Limited

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 F. HOFFMANN-LA ROCHE LTD.

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Takara Bio Inc.

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Luminex Corporation

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Omixon Inc.

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

12.11 The Sequencing Center

12.11.1 Key Facts

12.11.2 Business Description

12.11.3 Products and Services

12.11.4 Financial Overview

12.11.5 SWOT Analysis

12.11.6 Key Developments

12.12 HistoGenetics LLC

12.12.1 Key Facts

12.12.2 Business Description

12.12.3 Products and Services

12.12.4 Financial Overview

12.12.5 SWOT Analysis

12.12.6 Key Developments

12.13 CD Genomics

12.13.1 Key Facts

12.13.2 Business Description

12.13.3 Products and Services

12.13.4 Financial Overview

12.13.5 SWOT Analysis

12.13.6 Key Developments

12.14 Quintara Biosciences

12.14.1 Key Facts

12.14.2 Business Description

12.14.3 Products and Services

12.14.4 Financial Overview

12.14.5 SWOT Analysis

12.14.6 Key Developments

12.15 CREATIVE BIOLABS, INC.

12.15.1 Key Facts

12.15.2 Business Description

12.15.3 Products and Services

12.15.4 Financial Overview

12.15.5 SWOT Analysis

12.15.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES.

Table 1. North America: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 2. North America: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 3. North America: North America Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 4. North America: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 5. North America: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 6. North America: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 7. North America: North America Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 8. North America: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 9. US: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 10. US: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 11. US: North America Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 12. US: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 13. Canada: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 14. Canada: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 15. Canada: North America Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 16. Canada: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 17. Mexico: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 18. Mexico: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 19. Mexico: North America Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 20. Mexico: North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 21. Organic Developments in the North America Human Leukocyte Antigen (HLA) Testing Market

Table 22. Inorganic Developments in the North America Human Leukocyte Antigen (HLA) Testing Market

Table 23. Glossary of Terms, North America Human Leukocyte Antigen (HLA) Testing Market

The List of Companies - North America Human Leukocyte Antigen (HLA) Testing Market

● THERMO FISHER SCIENTIFIC INC.                            

● CareDx                                                                     

● QIAGEN                                                                                              

● Illumina, Inc.                                                                     

● Bio-Rad Laboratories, Inc.                                           

● TBG Diagnostics Limited                                                               

● F. HOFFMANN-LA ROCHE LTD.                                  

● Takara Bio Inc.                                                                  

● Luminex Corporation                                                    

● Omixon Inc.                                                                       

● The Sequencing Center                

● HistoGenetics LLC

● CD Genomics

● Quintara Biosciences

● CREATIVE BIOLABS, INC.

Reason To Buy

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America Human Leukocyte Antigen (HLA) Testing Market.

● Highlights key business priorities in order to assist companies to realign their business strategies.

● The key findings and recommendations highlight crucial progressive industry trends in North America Human Leukocyte Antigen (HLA) Testing Market, thereby allowing players across the value chain to develop effective long-term strategies.

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

● Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.

● Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(North America Human Leukocyte Antigen (HLA) Testing Market Forecast to 2028 )
  • Single User Price $3,000$2,400
  • Site Price $4,000$3,200
  • Enterprise Price $5,000$4,000
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry